LivaNova (LIVN) Free Cash Flow (2015 - 2026)
LivaNova's (LIVN) quarterly Free Cash Flow came in at $926000.0 in Q1 2026, down 92.97% year-on-year from $13.2 million in Q1 2025, and down 98.15% quarter-over-quarter from $50.2 million in Q4 2025.
LivaNova (LIVN) Free Cash Flow (2015 - 2026) Analysis & Trends
LivaNova has disclosed Free Cash Flow across 12 years of filings, most recently posting $926000.0 for Q1 2026.
- Free Cash Flow for Q1 2026 came in at $926000.0, down 92.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $161.0 million (up 10.66% YoY), and the FY2025 annual result was $173.3 million, up 27.48% from the prior year.
- Free Cash Flow came in at $926000.0 for Q1 2026 at LivaNova, down from $50.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $68.3 million in Q4 2024 to a low of -$23.6 million in Q2 2023.
- The 5-year median for Free Cash Flow is $20.6 million (2022), against an average of $23.1 million.
- Across the five-year window, Free Cash Flow sank 185.13% in 2022 and soared 328.87% in 2023, its largest moves.
- LivaNova's Free Cash Flow stood at $9.6 million in 2022, then jumped by 328.87% to $41.0 million in 2023, then soared by 66.43% to $68.3 million in 2024, then declined by 26.55% to $50.2 million in 2025, then plunged by 98.15% to $926000.0 in 2026.
- The last three Free Cash Flow figures came in at $926000.0 (Q1 2026), $50.2 million (Q4 2025), and $62.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | 926,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 926,000.00 |
| Mar 31, 2026 | 926,000.00 |
| Dec 31, 2025 | 50.16 Mn |
| Dec 31, 2025 | 50.16 Mn |
| Sep 30, 2025 | 62.18 Mn |
| Sep 30, 2025 | 62.18 Mn |
| Jun 30, 2025 | 47.77 Mn |
| Jun 30, 2025 | 47.77 Mn |
| Mar 31, 2025 | 13.18 Mn |
| Mar 31, 2025 | 13.18 Mn |
| Dec 31, 2024 | 68.30 Mn |
| Dec 31, 2024 | 68.30 Mn |
| Sep 30, 2024 | 32.85 Mn |
| Sep 30, 2024 | 32.85 Mn |
| Jun 30, 2024 | 31.20 Mn |
| Jun 30, 2024 | 31.20 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 41.04 Mn |
| Dec 31, 2023 | 41.04 Mn |